and CT-868, a Phase-2, once-daily subcutaneous injectable, dual GLP-1/GIP receptor agonist intended for the treatment of type 1 diabetes patients with overweight or obesity.
Peppermint oil capsules have antispasmodic properties that may reduce bloating and abdominal discomfort, though evidence for their effectiveness specifically in GLP-1-related bloating is limited
*The People like this are just some examples
That means these medications have a direct effect on your entire vascular system, not just your blood sugar
Current users reported fewer issues overall, with just 36 percent experiencing any side effects that their physicians attributed to the medication
If you notice these, see your doctor for a check-up and treatment